Eli Lilly and Company is working with the U.S. Food and Drug Administration’s Office of Criminal Investigations (FDA), and other law enforcement officials, to recover cases of select lots of pharmaceutical products that were stolen from one of Lilly’s United States distribution centers located in Enfield, Connecticut on March 14, 2010. A list of products stolen from the facility can be found at the bottom of this notice.

Product from the affected lots which had been delivered from Lilly to retailers, wholesalers or institutions prior to March 14 is not affected by this event. Product containing these lot numbers was previously distributed by Lilly within the United States, Puerto Rico and its territories. To assist the FDA and the law enforcement agencies in their investigation, Lilly stopped distributing product with the affected lot numbers on Monday, March 15, 2010.

These medicines require a prescription for purchase. Practitioners, pharmacies, and consumers are advised to purchase Lilly products only from well-established, trusted, and reputable sources and to be aware that an unusually low price is often an indication that a product has been stolen. Additionally, all pharmaceutical products should always be checked for signs of tampering or damage prior to purchase and/or use. Pharmacists and other health care professionals should not use the product if it has been removed from the sealed bottle or container, if the induction seal has been compromised, or in the case of glass vials, if the flip cap appears to have been disturbed in any way.More »

Hospitalization rates for heart patients taking warfarin, the world's most-prescribed blood thinner, dropped by approximately 30 percent when genetic information was available to doctors prescribing the drug, researchers from Medco Health Solutions, Inc.-- in association with the Medco Research Institute(TM) -- and Mayo Clinic announced today. Results of the first nationwide prospective study examining outcomes when incorporating genetic testing into the management of warfarin as part of the usual care of patients were presented at the American College of Cardiology's 59th annual scientific session and will be published in the Journal of the American College of Cardiology.More »